UROY UROY
Company Profile ↓Company Overview
UROY (UROY) is a publicly traded company listed on with a market capitalization of $521.87M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Return on capital employed stands at 15.9%.
Revenue has grown at a 164.2% CAGR over the past five years.
Maintains a net profit margin of 21.5%.
Carries low leverage with a debt-to-equity ratio of 0.04.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Apr 2026 Revenue of $186.95M (+1558.0% YoY); net profit $40.25M.
- Trailing 12 Months Year-on-year growth — revenue +1558.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 164.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 164.15% |
| 1 Year: | 1,557.96% |
Stock Price Performance
| 1 Year: | +41.83% |
| 6 Months: | -24.42% |
| 3 Months: | -6.56% |
| 1 Month: | +34.34% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)66.54 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 21.5%.
- Compounding revenue at 164.2% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 34.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 3.75M | 24.02M | 29.32K | 12.23M | 150.32M |
| Cost of Revenue | - | 3.18M | 20.18M | 20.74K | 8.73M | 100.46M |
| Gross Profit | - | 574.21K | 3.84M | 8.58K | 3.50M | 49.86M |
| Operating Expenses | - | 1.41M | 1.62M | 2.31M | 1.35M | 1.25M |
| Operating Income | - | -835.76K | 2.22M | -2.31M | 2.15M | 48.61M |
| EBITDA | - | -890.62K | 1.10M | 1.29M | 1.21M | 51.10M |
| Interest Expense | - | 3.36K | 2.89K | 2.86K | 2.94K | -8.07K |
| Pretax Income | - | -929.01K | 1.06M | 1.26M | 1.18M | 51.10M |
| Tax Provision | - | 57.03K | -42.67K | -213.13K | -260.53K | 14.91M |
| Net Income | - | -986.04K | 1.10M | 1.47M | 1.44M | 36.18M |
| Diluted EPS | -0.01 | - | 0.01 | 0.01 | 0.01 | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|
| Revenue | - | 10.14M | 31.21M | 11.28M | 186.95M |
| Cost of Revenue | - | 8.08M | 20.43M | 8.66M | 129.69M |
| Gross Profit | - | 2.06M | 10.78M | 2.62M | 57.26M |
| Operating Expenses | - | 4.83M | 5.69M | 6.06M | 6.61M |
| Operating Income | - | -2.77M | 5.09M | -3.44M | 50.65M |
| EBITDA | - | -3.07M | 16.90M | -5.29M | 54.75M |
| Interest Expense | - | 1.20M | 0 | 303.00K | 0 |
| Pretax Income | - | -4.29M | 16.90M | -5.64M | 54.64M |
| Tax Provision | - | -10.98K | 3.19M | -1.14M | 14.39M |
| Net Income | - | -4.28M | 13.71M | -4.51M | 40.25M |
| Diluted EPS | -0.04 | -0.04 | 0.12 | -0.04 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 136.03M | 203.91M | 216.12M | 373.32M |
| Current Assets | - | 101.65M | 169.56M | 172.59M | 329.30M |
| Cash & Equivalents | - | 10.47M | 15.44M | 9.37M | 241.96M |
| Inventory | - | 62.65M | 136.88M | 157.62M | 34.33M |
| Receivables | - | 0 | 10.11M | 31.00K | 59.00K |
| Total Liabilities | - | 7.63M | 2.13M | 1.02M | 60.55M |
| Current Liabilities | - | 7.57M | 2.02M | 739.00K | 55.48M |
| Long Term Debt | 10.01M | - | - | - | - |
| Total Debt | - | 7.23M | 141.21K | 153.00K | 114.00K |
| Total Equity | - | 128.40M | 201.78M | 215.10M | 312.77M |
| Shares Outstanding | - | 99.80M | 120.55M | 133.64M | 146.59M |
Cash Flows (Annual)
Figures in USD.
| Metric | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -8.39M | -76.43M | -15.06M | 178.46M |
| Investing Cash Flow | - | 8.92M | 32.49M | -8.59M | 798.00K |
| Financing Cash Flow | - | 6.73M | 49.24M | 18.45M | 93.70M |
| Capital Expenditure | - | -1.59M | -56.00K | -8.34M | -763.00K |
| Free Cash Flow | - | -9.98M | -76.49M | -23.39M | 177.69M |
| Net Change in Cash | - | 7.26M | 5.30M | -5.21M | 272.95M |
Ratios (Annual)
Figures in %.
| Metric | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 20.3% | 34.5% | 23.2% | 30.6% |
| Operating Margin % | - | -27.3% | 16.3% | -30.5% | 27.1% |
| Net Margin % | - | -42.2% | 43.9% | -40.0% | 21.5% |
| ROE % | - | -3.3% | 6.8% | -2.1% | 12.9% |
| ROCE % | - | -2.2% | 2.5% | -1.6% | 15.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for UROY
Uranium Royalty Completes Landmark Sweetwater Transaction Creating Leading Uranium and Land Royalty Company
Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) ("URC" or the "Company") is pleased to announce that it has completed its previously announced plan of arrangement transaction (the "Arrangement").
Uranium Royalty (UROY) Fell Despite Stable Uranium Spot Prices
Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q2 2026 investor letter. A copy of the letter is available to download here. In Q2 2026, the Micro Opportunities strategy underperformed the …
Uranium Royalty Corp. Obtains Shareholder Approval for Arrangement and Provides Corporate Update
Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) ("URC" or the "Company") is pleased to announce shareholder approval of its previously announced plan of arrangement, as contemplated by an arrangement agreement, dated as of April 16, 2026 (t…
Uranium Royalty Corp. Announces Filing and Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders to Approve Proposed Plan of Arrangement with Sweetwater Investors and Announces Exchangeable Share Election Deadline
Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) ("URC" or the "Company") is pleased to announce that it has filed and mailed its management information circular (the "Circular") and related proxy materials for its special meeting of shareho…
Upcoming Meeting Dates - May 25, 2026
Toronto, Ontario--(Newsfile Corp. - May 25, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies through the service of CDS Clearing and Dep…
What Does Raymond James Think About Uranium Royalty (UROY) After Its Sweetwater Merger?
Uranium Royalty Corp. (NASDAQ:UROY) is one of the best uranium stocks to buy according to Wall Street analysts. On April 21, Raymond James analyst Brian MacArthur upgraded Uranium Royalty Corp. (NASDAQ:UROY) from Market Perform to Outperfor…
UROY — Frequently Asked Questions
What is the current share price of UROY?
As of 2026-08-05 17:25 PDT, UROY trades at $3.56 on NASDAQ/NYSE. Its 52-week range is $2.51 to $5.46.
What is the market capitalisation of UROY?
UROY has a market capitalisation of $521.87M on NASDAQ/NYSE.
What is the P/E ratio of UROY?
UROY trades at a trailing price-to-earnings (P/E) ratio of -89.00. Its price-to-book (P/B) ratio is 1.67.
What is the return on equity (ROE) of UROY?
UROY has a return on equity (ROE) of 12.87%. Its return on capital employed (ROCE) is 15.93%.
Is UROY a good stock to buy?
This page provides a data-driven analysis of UROY, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.